NEWS BRIEF · Research journal
Blood-based RNA biomarker for the early detection of ovarian cancer
From the report
Nature Medicine, Published online: 10 November 2026; doi:10.1038/s41591-026-04732-9Tested in a cohort of 506 individuals, the RNA-based biomarker of microenvironment fitness Tu-stroma shows high performance in discriminating early-stage ovarian cancer from benign lesions, outperforming CA125.
